Onconetix, Inc. (ONCO) stock forecast & analysis
0.6390
NasdaqCM · USD
Down: -0.0230, -3.5%
0.6569Up: +0.0179, +2.8%
1 analysis
- Open
- 0.6700
- Previous close
- 0.6620
- Day range
- 0.6390 – 0.6800
- 52-week range
- 0.5860 – 209.50
- Volume (shares)
- 170.75K
- Net assets
- Not available
- Expense ratio
- Not available
- Shares outstanding
- 4.38M
- P/E ratio
- 0.00
- Dividend yield
- Not available
- Beta
- 2.68
- Market cap
- 2.80M
Market Scanner’s AI analysis of Onconetix, Inc. (ONCO), updated September 2026: ONCO's recent surge follows a prior downtrend, with mixed technical signals and significant revenue decline.
This page is the public summary. A signed-in user can run a fresh five-stage AI analysis of Onconetix, Inc. (ONCO) and read the full verdict with the bull and bear debate behind it — using Market Scanner tokens, or their own OpenAI or Anthropic key.
Summary
ONCO's recent surge follows a prior downtrend, with mixed technical signals and significant revenue decline.
Recent analyses for Onconetix, Inc. (ONCO) covered its market performance and financial standing. The company's stock experienced a notable 7-day price increase, recovering from a previous decline, though long-term trends remain challenged. Financials indicate a substantial year-over-year decrease in quarterly revenue and continued negative profitability.
ONCO technical picture
ONCO's price action showed strong recent upward momentum, trading above its 50-day SMA and 10-day EMA. However, the stock remained significantly below its 200-day SMA, indicating a long-term downtrend. Momentum indicators suggested strong buying pressure approaching overbought territory.
Fundamentals
The company's quarterly revenue saw a significant year-over-year decrease, accompanied by negative operating and net income. Profitability metrics such as operating margin and return on equity were also negative on a trailing twelve-month basis.
Factors discussed — upside
- Significant 7-day price increase of +66.7%
- Trading above 50-day SMA
- RSI approaching overbought territory
- MFI indicating strong buying pressure
Factors discussed — risks
- Trading significantly below 200-day SMA
- Substantial year-over-year quarterly revenue decrease of 83.9%
- Negative operating and net income across all reported periods
- Gross profit decreased significantly year-over-year
- Market performance
- Technical indicators
- Financial performance
- Revenue trends
Summary updated .
ONCO technical indicators
Common technical indicators for ONCO, computed from its daily closing prices.
| Indicator | Value | Reading |
|---|---|---|
| 50-day simple moving average | 0.78 | Price below |
| 10-day exponential moving average | 0.69 | Price below |
| Relative strength index (14-day) | 41.43 | Neutral |
| MACD line (12/26/9) | -0.0426 | Below its signal line |
| Bollinger bands (20-day, 2σ) | 0.50 – 0.89 | Price inside the bands |
Analyses
Recent ONCO.US analyses are locked — sign in to read them or generate a fresh one.
Frequently asked questions
- What is the bull case for Onconetix, Inc.?
- The recent analyses highlighted a significant 7-day price increase, with the stock trading above its 50-day moving average and showing strong buying pressure indicated by RSI and MFI readings approaching overbought territory.
- What are the risks for Onconetix, Inc.?
- The company faces headwinds from trading significantly below its 200-day moving average, a substantial year-over-year decrease in quarterly revenue, and persistent negative operating and net income, alongside a year-over-year decline in gross profit.
- Is Onconetix, Inc. bullish or bearish?
- Recent AI analyses of Onconetix, Inc. examined factors on both sides. Discussed upside: The recent analyses highlighted a significant 7-day price increase, with the stock trading above its 50-day moving average and showing strong buying pressure indicated by RSI and MFI readings approaching overbought territory. Discussed risks: The company faces headwinds from trading significantly below its 200-day moving average, a substantial year-over-year decrease in quarterly revenue, and persistent negative operating and net income, alongside a year-over-year decline in gross profit. These are descriptive observations, not a recommendation.
- What is the latest sentiment on Onconetix, Inc.?
- Recent analyses for Onconetix, Inc. (ONCO) covered its market performance and financial standing. The company's stock experienced a notable 7-day price increase, recovering from a previous decline, though long-term trends remain challenged. Financials indicate a substantial year-over-year decrease in quarterly revenue and continued negative profitability.
- How does Market Scanner analyse Onconetix, Inc.?
- Every analysis of Onconetix, Inc. runs the same five stages: four analysts read the market independently, a bull and a bear debate what they found, one agent turns the ruling into a position, three risk perspectives stress-test it, and a final agent writes the report. Market Scanner publishes what each stage does, with figures computed from the analyses on the platform rather than written in by hand.Read the methodology
- Bundles used
- gemini-low-v2
Run a fresh ONCO.US analysis
Configure the ticker, model bundle and debate depth here — you only sign in at the end, and everything you picked comes with you.
Or sign in to read every ONCO.US report already in the library